Serpil Timuray Joins BAT Board as Independent Director

BAT by 2FIRSTS.ai

Dec.05.2023

Serpil Timuray Joins BAT Board as Independent Director

BAT announces Serpil Timuray, CEO of Vodafone Europe Cluster, as an independent non-executive director on its board.

Tobacco giant British American Tobacco (BAT) announced on December 4th that Serpil Timuray has joined the board of directors as an independent non-executive director and will also be a member of the nomination and remuneration committee, according to Marketscreener.

Serpil Timuray is currently the Chief Executive Officer of the Vodafone Group's Europe Cluster, and also a member of the Vodafone Group Executive Committee. She joined Vodafone in 2009 and has held various positions since then.

Vodafone is an international mobile telecommunications company based in the United Kingdom. It is one of the world's largest mobile telecommunications operators and has a wide-ranging international network and operations. Vodafone offers a variety of mobile communication services including voice calls, text messaging, data services, and fixed-line telephone services.

References:

[1] BAT: Serpil Timuray joins the Board of Directors

Also Read:

[1] BAT Appoints Soraya Benchikh as New CFO

[2] Cora Koppe-Stahrenberg Appointed as BAT Chief HR Officer

#Europe #United Kingdom #Regulation #British American Tobacco (BAT)

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions

QISI’s Dongguan factory has posted new production job openings, following earlier reports of a shutdown at its Zhuhai site.

Oct.15

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly

Over 1,200 UK health leaders urged Parliament to pass the Tobacco and Vapes Bill quickly, calling it vital to protect future generations. The bill would ban tobacco sales to anyone born after Jan 1, 2009, and restrict vape packaging and flavours. Health groups warned delays risk undermining “gamechanging” public health reforms.

Oct.27 by 2FIRSTS.ai

Bremen Sees Active Illicit Trade in E-Cigarettes and Nicotine Pouches; Regulators Say ‘Nearly Every Inspection Finds Violations’

Bremen’s state government warns of increasingly active illicit trade in e-cigarettes, snus, and nicotine pouches. Enforcement reports “violations in nearly every inspection,” with some disposable vapes exceeding Germany’s 2 ml e-liquid cap. Since 2024, authorities have recorded 54 violations in 255 checks, concentrated around the central station district and city center.